128 related articles for article (PubMed ID: 34129194)
1. Baicalin attenuates adriamycin-induced nephrotic syndrome by regulating fibrosis procession and inflammatory reaction.
Tan N; Sun CX; Zhu HJ; Li DY; Huang SG; He SD
Genes Genomics; 2021 Sep; 43(9):1011-1021. PubMed ID: 34129194
[TBL] [Abstract][Full Text] [Related]
2. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of glycyrrhizin on nephrotic syndrome induced by adriamycin in rats.
Bi X; Zhu G; Han Z; Ye Y; Liang Y; Zhang L; Hao Z; Zeng G; He H; Zhong W
Clin Invest Med; 2009 Jun; 32(3):E229-38. PubMed ID: 19480741
[TBL] [Abstract][Full Text] [Related]
4. NAC attenuates adriamycin-induced nephrotic syndrome in rats through regulating TLR4 signaling pathway.
Yao H; Cai ZY; Sheng ZX
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1938-1943. PubMed ID: 28485782
[TBL] [Abstract][Full Text] [Related]
5. Tripterygium glycoside fraction n2 ameliorates adriamycin-induced nephrotic syndrome in rats by suppressing apoptosis.
Wang XW; Tian RM; Yang YQ; Wang K; Li EN; Han XD; Bao K; Mao W; Xu HT; Liu B; Xu P
J Ethnopharmacol; 2020 Jul; 257():112789. PubMed ID: 32234597
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the mechanism of Danggui-Shaoyao-San in regulating the metabolome of nephrotic syndrome based on urinary metabonomics and bioinformatics approaches.
Wang Y; Fan S; Yang M; Shi G; Hu S; Yin D; Zhang Y; Xu F
J Ethnopharmacol; 2020 Oct; 261():113020. PubMed ID: 32592886
[TBL] [Abstract][Full Text] [Related]
7. Baicalin ameliorates renal fibrosis via inhibition of transforming growth factor β1 production and downstream signal transduction.
Zheng L; Zhang C; Li L; Hu C; Hu M; Sidikejiang N; Wang X; Lin M; Rong R
Mol Med Rep; 2017 Apr; 15(4):1702-1712. PubMed ID: 28260014
[TBL] [Abstract][Full Text] [Related]
8. Uncovering the mechanism of Astragali Radix against nephrotic syndrome by intergrating lipidomics and network pharmacology.
Li AP; Yang L; Cui T; Zhang LC; Liu YT; Yan Y; Li K; Qin XM
Phytomedicine; 2020 Oct; 77():153274. PubMed ID: 32771537
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of mesenchymal stromal cells on adriamycin-induced minimal change nephrotic syndrome in rats and possible mechanisms.
Guo J; Zou Y; Wu Z; Wu W; Xu Z; Hu H; Huang L; Dong H; Chen J; Lu J; Fu Y; Wang J; Ma Y; Chen X; He F; Yang S; Liao L; Chen J; Zheng F; Tan J
Cytotherapy; 2014 Apr; 16(4):471-84. PubMed ID: 24119646
[TBL] [Abstract][Full Text] [Related]
10. Paeoniflorin ameliorates Adriamycin-induced nephrotic syndrome through the PPARγ/ANGPTL4 pathway in vivo and vitro.
Lu R; Zhou J; Liu B; Liang N; He Y; Bai L; Zhang P; Zhong Y; Zhou Y; Zhou J
Biomed Pharmacother; 2017 Dec; 96():137-147. PubMed ID: 28972886
[TBL] [Abstract][Full Text] [Related]
11. Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT.
Dou Y; Shang Y; Shen Y; Qu J; Liu C; Cao J
Life Sci; 2020 Sep; 257():118010. PubMed ID: 32598932
[TBL] [Abstract][Full Text] [Related]
12. Renal antioxidant enzymes and fibrosis-related markers in the rat adriamycin model.
Van den Branden C; Ceyssens B; De Craemer D; Pauwels M; Vanden Houte K; De Bleser P; Hellemans K; Geerts A; Verbeelen D
Nephron; 2000 Oct; 86(2):167-75. PubMed ID: 11014987
[TBL] [Abstract][Full Text] [Related]
13. Mild electrical stimulation with heat shock attenuates renal pathology in adriamycin-induced nephrotic syndrome mouse model.
Teramoto K; Tsurekawa Y; Suico MA; Kaseda S; Omachi K; Yokota T; Kamura M; Piruzyan M; Kondo T; Shuto T; Araki E; Kai H
Sci Rep; 2020 Oct; 10(1):18719. PubMed ID: 33128027
[TBL] [Abstract][Full Text] [Related]
14. ICRF-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats.
Zima T; Tesar V; Crkovská J; Stejskalová A; Pláteník J; Temínová J; Nemecek K; Janebová M; Stípek S
Nephrol Dial Transplant; 1998 Aug; 13(8):1975-9. PubMed ID: 9719150
[TBL] [Abstract][Full Text] [Related]
15. The pregnancy coexisting with experimentally induced nephrotic syndrome (NS) in rats--the histological assessment of kidneys in light microscopy.
Pedrycz A; Wieczorski M; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):225-31. PubMed ID: 16145985
[TBL] [Abstract][Full Text] [Related]
16. Nephrotic syndrome (NS) and pregnancy in rat--evaluation of kidney in electron microscopy.
Pedrycz A; Wieczorski M; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):220-4. PubMed ID: 16145984
[TBL] [Abstract][Full Text] [Related]
17. The progression of adriamycin-induced nephrotic syndrome in rats and the effect of captopril.
Hall RL; Wilke WL; Fettman MJ
Toxicol Appl Pharmacol; 1986 Jan; 82(1):164-74. PubMed ID: 3511565
[TBL] [Abstract][Full Text] [Related]
18. Baicalin protects against zearalenone-induced chicks liver and kidney injury by inhibiting expression of oxidative stress, inflammatory cytokines and caspase signaling pathway.
Xu J; Li S; Jiang L; Gao X; Liu W; Zhu X; Huang W; Zhao H; Wei Z; Wang K; Yang Z
Int Immunopharmacol; 2021 Nov; 100():108097. PubMed ID: 34521024
[TBL] [Abstract][Full Text] [Related]
19. Pefloxacin in adriamycin induced nephrotic syndrome in the rat.
Korzets Z; Pomeranz A; Golan E; Bernheim J
Nephrol Dial Transplant; 1997 Feb; 12(2):286-8. PubMed ID: 9132646
[TBL] [Abstract][Full Text] [Related]
20. Effect of the lipoprotein lipase activator NO-1886 on adriamycin-induced nephrotic syndrome in rats.
Nakayama K; Hara T; Kusunoki M; Tsutsumi K; Minami A; Okada K; Sakamoto S; Ohnaka M; Miyata T; Nakamura T; Aoki T; Fukatsu A; Nakaya Y; Kakumu S
Metabolism; 2000 May; 49(5):588-93. PubMed ID: 10831167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
